A, F., S. D, A. R, K. M, Allah SA, Marzouk S, A. M, Abd El Aziz R, El Badri A, K. H, et al.,
"Comparative diagnostic study of biomarkers using FibroMax™ and pathology for prediction of liver steatosis in patients with chronic hepatitis C virus infection: an Egyptian study.",
Int J Gen Med, vol. 12, issue 6, pp. 127-34, 2013.
H, F., Raziky MS, Aziz RA, S. D, Aziz GM, Ewais M, and S. AR.,
"Dendritic cell co-stimulatory and co-inhibitory markers in chronic HCV: an Egyptian study.",
World journal of gastroenterology: WJG, vol. 19, issue 43, pp. 7711-8, 2013.
MA1, A., S. D, R. LA, A. WM, el-Ghobary MA, F. MS, F. HA, and Y. YA.,
"Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study",
Clin Transplant., vol. 27, issue 4, pp. 607-12, 2013.
AbstractStem cell-based therapy has received attention as a possible alternative to organ transplantation. The aim of this study was to assess the safety and efficacy of autologous transplantation of bone marrow (BM)-derived stromal cells in post-HCV liver cirrhosis patients.
METHODOLOGY:
10 × 10(6) of isolated human bone marrow (HBM)-stromal cells in 10 mL normal saline were injected in the spleen of 20 patients with end-stage liver cirrhosis guided by the ultrasonography, and then patients were followed up on monthly basis for six months.
RESULTS:
A statistically significant decrease was detected in the total bilirubin, aspartate transaminase (AST), alanine transaminase (ALT) (p-value<0.01), prothrombin time (PT), and international normalized ratio (INR) levels (p-value<0.05), while a statistically significant increase in the albumin and PC (p-value<0.05) after follow-up.
CONCLUSION:
This study suggested the safety, feasibility, and efficacy of the intrasplenic injection of autologous BM stromal cells in improving liver function in Egyptian patients with cirrhosis.
© 2013 John Wiley & Sons A/S.
MT, A., El Ibrashy IN, M. DP, R. AM, W. MA, F. HH, A. HH, Sabry DA, Shawky HM, and H. RE.,
"Signaling mechanisms of a water soluble curcumin derivative in experimental type 1 diabetes with cardiomyopathy.",
Diabetol Metab Syndr., vol. 12, issue 5, pp. 13, 2013.